Literature DB >> 31767561

A new prognostic model for primary sclerosing cholangitis.

Şencan Acar1, Murat Akyıldız2.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31767561      PMCID： PMC6883998          DOI： 10.5152/tjg.2019.301019

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN： 1300-4948            Impact factor:   1.852


× No keyword cloud information.
  8 in total

1.  Natural history and prognostic variables in primary sclerosing cholangitis.

Authors:  J M Farrant; K M Hayllar; M L Wilkinson; J Karani; B C Portmann; D Westaby; R Williams
Journal:  Gastroenterology       Date:  1991-06       Impact factor: 22.682

2.  A revised natural history model for primary sclerosing cholangitis.

Authors:  W R Kim; T M Therneau; R H Wiesner; J J Poterucha; J T Benson; M Malinchoc; N F LaRusso; K D Lindor; E R Dickson
Journal:  Mayo Clin Proc       Date:  2000-07       Impact factor: 7.616

3.  Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.

Authors:  U Broomé; R Olsson; L Lööf; G Bodemar; R Hultcrantz; A Danielsson; H Prytz; H Sandberg-Gertzén; S Wallerstedt; G Lindberg
Journal:  Gut       Date:  1996-04       Impact factor: 23.059

4.  Primary sclerosing cholangitis: refinement and validation of survival models.

Authors:  E R Dickson; P A Murtaugh; R H Wiesner; P M Grambsch; T R Fleming; J Ludwig; N F LaRusso; M Malinchoc; R W Chapman; M M Kaplan
Journal:  Gastroenterology       Date:  1992-12       Impact factor: 22.682

5.  Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis.

Authors:  R H Wiesner; P M Grambsch; E R Dickson; J Ludwig; R L MacCarty; E B Hunter; T R Fleming; L D Fisher; S J Beaver; N F LaRusso
Journal:  Hepatology       Date:  1989-10       Impact factor: 17.425

6.  Primary Sclerosing Cholangitis Risk Estimate Tool (PREsTo) Predicts Outcomes of the Disease: A Derivation and Validation Study Using Machine Learning.

Authors:  John E Eaton; Mette Vesterhus; Bryan M McCauley; Elizabeth J Atkinson; Erik M Schlicht; Brian D Juran; Andrea A Gossard; Nicholas F LaRusso; Gregory J Gores; Tom H Karlsen; Konstantinos N Lazaridis
Journal:  Hepatology       Date:  2018-12-28       Impact factor: 17.425

7.  A novel prognostic model for transplant-free survival in primary sclerosing cholangitis.

Authors:  Elisabeth M de Vries; Junfeng Wang; Ronald B Geskus; Cyriel Y Ponsioen; Kate D Williamson; Mariska M Leeflang; Kirsten Boonstra; Rinse K Weersma; Ulrich Beuers; Roger W Chapman
Journal:  Gut       Date:  2017-07-24       Impact factor: 23.059

8.  Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring System.

Authors:  Elizabeth C Goode; Allan B Clark; George F Mells; Brijesh Srivastava; Kelly Spiess; William T H Gelson; Palak J Trivedi; Kate D Lynch; Edit Castren; Mette N Vesterhus; Tom H Karlsen; Sun-Gou Ji; Carl A Anderson; Douglas Thorburn; Mark Hudson; Michael A Heneghan; Mark A Aldersley; Andrew Bathgate; Richard N Sandford; Graeme J Alexander; Roger W Chapman; Martine Walmsley; Gideon M Hirschfield; Simon M Rushbrook
Journal:  Hepatology       Date:  2019-03-04       Impact factor: 17.425
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.